Relation of the changes in Y Sway Amplitude and LFS induced by postural training with those in 95% Area. by Cristina Dolciotti (16317330)

Subjects:

Training-induced changes in bipedal stance. by Cristina Dolciotti (16317330)

Subjects:

Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training. by Cristina Dolciotti (16317330)

Subjects:

Relation between training-related changes in unipedal and bipedal stance. by Cristina Dolciotti (16317330)

Subjects:

Consolidation of training-induced changes in unipedal stance: 95% Area, Y Sway Amplitude and LFS. by Cristina Dolciotti (16317330)

Subjects:

Consolidation of training-induced changes in unipedal stance: Path Length, X Sway Amplitude and Velocity. by Cristina Dolciotti (16317330)

Subjects:

Time course of 95% Area, X and Y Amplitude Sway during postural training. by Cristina Dolciotti (16317330)

Subjects:

Correlations between unipedal and bipedal stance parameters recorded at the beginning of the training and of the control session. by Cristina Dolciotti (16317330)

Subjects:

Flow diagram. by Cristina Dolciotti (16317330)

Subjects:

Image 1_circWWC3 enhances the progression of triple-negative breast cancer by interacting with vimentin to regulate the secretion of CSF2.tif by Ming Wu (238132)

“…Introduction<p>Circular RNAs (circRNAs) have been reported to be important in the development and progression of breast cancer. Nevertheless, the biological functions and mechanisms underlying the action of circRNAs in triple-negative breast cancer (TNBC) remain poorly understood. …”

Image 2_circWWC3 enhances the progression of triple-negative breast cancer by interacting with vimentin to regulate the secretion of CSF2.tif by Ming Wu (238132)

“…Introduction<p>Circular RNAs (circRNAs) have been reported to be important in the development and progression of breast cancer. Nevertheless, the biological functions and mechanisms underlying the action of circRNAs in triple-negative breast cancer (TNBC) remain poorly understood. …”

Data Sheet 2_Case Report: Possible association between dermatomyositis and Trastuzumab Deruxtecan therapy of triple-negative breast cancer patient.zip by Huan Han (9287828)

“…Lymph node biopsy confirmed triple-negative breast cancer (cT2N3cM0, stage IIIC) with HER2 ultra-low expression (1+). …”

Data Sheet 1_Case Report: Possible association between dermatomyositis and Trastuzumab Deruxtecan therapy of triple-negative breast cancer patient.pdf by Huan Han (9287828)

“…Lymph node biopsy confirmed triple-negative breast cancer (cT2N3cM0, stage IIIC) with HER2 ultra-low expression (1+). …”

Table 2_Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer.xlsx by Chuanzhi Chen (11492671)

“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive form of cancer that lacks specific targeted therapies. …”

Table 6_Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer.xlsx by Chuanzhi Chen (11492671)

“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive form of cancer that lacks specific targeted therapies. …”

Table 3_Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer.xlsx by Chuanzhi Chen (11492671)

“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive form of cancer that lacks specific targeted therapies. …”

Image 2_Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer.jpeg by Chuanzhi Chen (11492671)

“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive form of cancer that lacks specific targeted therapies. …”

Table 1_Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer.xlsx by Chuanzhi Chen (11492671)

“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive form of cancer that lacks specific targeted therapies. …”

Image 4_Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer.jpeg by Chuanzhi Chen (11492671)

“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive form of cancer that lacks specific targeted therapies. …”

Table 7_Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer.xlsx by Chuanzhi Chen (11492671)

“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive form of cancer that lacks specific targeted therapies. …”